Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts

AI justification

[Auto-resolved by learned corrector: learned-map — A=MINT/B=NEUTRAL -> MINT (human chose this in 93% of 255 past reviews)] AG's action punishes harm by blocking data requirements that restrict 340B access for vulnerable groups. | The action protects access to affordable medicines for vulnerable populations (SDG 3, 10) by removing a potential barrier to 340B participation. However, it risks undermining accountability mechanisms and national policy coherence. The net ethical judgment leans positiv